Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Nov;98(2):285-94.
doi: 10.1016/j.diabres.2012.09.023. Epub 2012 Oct 22.

Improving diabetes care: multi-component cardiovascular disease risk reduction strategies for people with diabetes in South Asia--the CARRS multi-center translation trial

Collaborators, Affiliations
Randomized Controlled Trial

Improving diabetes care: multi-component cardiovascular disease risk reduction strategies for people with diabetes in South Asia--the CARRS multi-center translation trial

CARRS Trial Writing Group et al. Diabetes Res Clin Pract. 2012 Nov.

Abstract

Aims: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in people with diabetes in South Asia. The CARRS Translation Trial tests the effectiveness, cost-effectiveness, and sustainability of a clinic-based multi-component CVD risk reduction intervention among people with diabetes in India and Pakistan.

Methods: We randomly assigned 1146 adults with diabetes recruited from 10 urban clinic sites, to receive usual care by physicians or to receive an integrated multi-component CVD risk reduction intervention. The intervention involves electronic health record management, decision-support prompts to the healthcare team, and the support of a care coordinator to actively facilitate patient and provider adherence to evidence-based guidelines. The primary outcome is a composite of multiple CVD risk factor control (blood glucose and either blood pressure or cholesterol, or all three). Other outcomes include control of the individual CVD risk factors, process and patient-centered measures, cost-effectiveness, and acceptability/feasibility.

Conclusion: The CARRS Translation Trial tests a low-cost diabetes care delivery model in urban South Asia to achieve comprehensive cardio-metabolic disease case-management of high-risk patients (clinicaltrials.gov number: NCT01212328).

PubMed Disclaimer

Figures

Figure 1
Figure 1. CARRS Translation Trial Schematic: design, participant flow and study measures
HbA1c=glycated hemoglobin, SBP=systolic blood pressure, LDLc=low density lipoprotein cholesterol, Ht=height, Wt=weight, WC=waist circumference, BP=blood pressure, HR=heart rate, FBG=fasting blood glucose, ECG=electrocardiogram, DSS=decision-support software
Figure 2
Figure 2. Intervention arm: care coordinator functions and electronic health record/decision-support software interactions for patient case-management
txt msg = text message, call = phone call, DSS=decision-support software, EHR= electronic health records, CC=care coordinator
  1. CC checks EHR to track which patients have upcoming visits. CC sends reminder (text message or phone call) to patient to visit clinic and get needed lab tests done for visit evaluation.

  2. During clinic visit, CC first takes the patient’s intake (history, labs, measurements) and enters the information into the EHR to patient-specific DSS prompts.

  3. CC takes patient to physician and conveys the patient’s status and the treatment DSS prompts to the physician. Physician conducts any exam, updates the plan accounting for the DSS prompts, and provides patient education and needed prescriptions/referrals. The CC updates the response to the DSS prompts (accepted or rejected) and treatment plan in the EHR, including any reminders to schedule.

  4. CC checks EHR to track and send patient reminders for referrals, lab tests, or pharmacy.

  5. CC checks EHR to track and send patient reminders for self-care and motivation.

References

    1. Kempler P. Learning from large cardiovascular clinical trials: classical cardiovascular risk factors. Diabetes Res Clin Pract. 2005;68(Suppl1):S43–7. - PubMed
    1. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New Engl J Med. 2003;348:383–93. - PubMed
    1. Narayan KMV. The Steno Diabetes Study. Clin. Diabetes. 2004;22:34–5.
    1. Yusuf S. Two decades of progress in preventing vascular disease. Lancet. 2002;360:2–3. - PubMed
    1. American Diabetes Association Standards of Medical Care in Diabetes 2009. Diabetes Care. 2009;32:S13–S61. - PMC - PubMed

Publication types

Associated data